In a world’s first, British researchers will examine whether jabs developed by Pfizer and AstraZeneca can be safely combined as part of a two-dose Covid-19 vaccine regimen. Formally known as the Covid-19 Heterologous Prime Boost study, or ‘Com-Cov’, the trial is designed to gauge the effects of using two different vaccines, and timetables, for the first and second dose. For example, one group will be given the Oxford/AstraZeneca vaccine for the first dose, followed by the Pfizer/BioNTech vaccine for the second, with the drugs being administered. Others will receive the Pfizer jab first, followed by the AstraZeneca variant. The trial wi
Hence then, the article about uk launches first ever trial to test safety of mixing pfizer astrazeneca covid jabs was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( UK launches first-ever trial to test safety of mixing Pfizer & AstraZeneca Covid jabs )